Ahmed A. Awan, MD, on the Management of HCV in Chronic Kidney Disease
In this podcast, Ahmed A. Awan, from Baylor College of Medicine, discusses the management of hepatitis C virus (HCV) infection among patients with chronic kidney disease (CKD) according to the most recent clinical practice guideline from Kidney Disease: Improving Global Outcomes (KDIGO), how direct-acting agents for the management of HCV infection affect the management of CKD, the role of interferon-free regimens, and more.
Ahmed A. Awan, MD, is an assistant professor in the Division of Abdominal Transplantation at Baylor College of Medicine in Houston, Texas.
Awan AA, Jadoul M, Martin P. Hepatitis C in chronic kidney disease: an overview of the KDIGO guideline [published online July 31, 2019]. Clin Gastroenterol Hepatol. doi:10.1016/j.cgh.2019.07.050.